• Science & Technology

Antibiotic shows potential in helping treat aggressive blood cancer

New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea. New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea.

24 February 2021

• Science & Technology

Gentle regular exercise could reduce the risk of liver cancer in mice

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

15 February 2021

• Health & Medicine

Men with early stage testicular cancer could avoid potentially harmful monitoring scans

Men who have had treatment for early stage testicular cancer could benefit from fewer monitoring scans, reducing their exposure to harmful radiation. Men who have had treatment for early stage testicular cancer could benefit from fewer monitoring scans, reducing their exposure to harmful radiation.

12 February 2021

• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021

• Health & Medicine

Transforming optimism: finding new ways to treat rare cancers

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

27 January 2021

• Science & Technology
• Health & Medicine

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Health & Medicine
• Science & Technology

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Science & Technology

Scientists develop approach for exploiting cancer’s dietary demands

Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease. Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.

13 January 2021

• Health & Medicine

Ultraviolet radiation causes rare type of eye cancer

Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma. Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma.

11 January 2021

• Health & Medicine

Striking differences seen in COVID-19 responses in cancer patients

A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer. A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer.

5 January 2021

• Policy & Insight
• Science & Technology

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Science & Technology

Scientists develop new drug that targets pathway found in several hard-to-treat cancers

After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers. After decades of no luck, scientists have finally found a way to target the KRAS mutation - a common mutation found in several hard-to-treat cancers.

30 December 2020